NO155098C - Analogifremgangsmaate ved fremstilling av farmasoeytisk aktive aza-bicyklo-oktan-karboksylsyrer. - Google Patents

Analogifremgangsmaate ved fremstilling av farmasoeytisk aktive aza-bicyklo-oktan-karboksylsyrer.

Info

Publication number
NO155098C
NO155098C NO813541A NO813541A NO155098C NO 155098 C NO155098 C NO 155098C NO 813541 A NO813541 A NO 813541A NO 813541 A NO813541 A NO 813541A NO 155098 C NO155098 C NO 155098C
Authority
NO
Norway
Prior art keywords
pharmasoytic
bicyclo
octane
preparation
carboxyl acids
Prior art date
Application number
NO813541A
Other languages
English (en)
Norwegian (no)
Other versions
NO155098B (no
NO813541L (no
Inventor
Michel Vincent
Georges Remond
Michel Laubie
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO813541L publication Critical patent/NO813541L/no
Publication of NO155098B publication Critical patent/NO155098B/no
Publication of NO155098C publication Critical patent/NO155098C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO813541A 1980-10-21 1981-10-20 Analogifremgangsmaate ved fremstilling av farmasoeytisk aktive aza-bicyklo-oktan-karboksylsyrer. NO155098C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8022438A FR2492381A1 (fr) 1980-10-21 1980-10-21 Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme

Publications (3)

Publication Number Publication Date
NO813541L NO813541L (no) 1982-04-22
NO155098B NO155098B (no) 1986-11-03
NO155098C true NO155098C (no) 1987-02-11

Family

ID=9247120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813541A NO155098C (no) 1980-10-21 1981-10-20 Analogifremgangsmaate ved fremstilling av farmasoeytisk aktive aza-bicyklo-oktan-karboksylsyrer.

Country Status (29)

Country Link
US (1) US4397857A (es)
EP (1) EP0051020B1 (es)
JP (2) JPS5798281A (es)
KR (1) KR860001877B1 (es)
AR (1) AR228621A1 (es)
AT (1) ATE8892T1 (es)
AU (1) AU540609B2 (es)
CA (1) CA1183140A (es)
DD (1) DD201891A5 (es)
DE (1) DE3165428D1 (es)
DK (1) DK162444C (es)
EG (1) EG15419A (es)
ES (1) ES506222A0 (es)
FI (1) FI73678C (es)
FR (2) FR2492381A1 (es)
GR (1) GR75389B (es)
HU (1) HU185058B (es)
IE (1) IE51823B1 (es)
IL (1) IL64075A0 (es)
MA (1) MA19307A1 (es)
MX (1) MX155032A (es)
NO (1) NO155098C (es)
NZ (1) NZ198701A (es)
OA (1) OA06930A (es)
PH (1) PH17338A (es)
PT (1) PT73857B (es)
SU (1) SU1138022A3 (es)
YU (1) YU42587B (es)
ZA (1) ZA817251B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19575012I2 (de) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
IE54551B1 (en) * 1982-01-22 1989-11-22 Ici Plc Amide derivatives
DE3227055A1 (de) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung
DE3246757A1 (de) * 1982-12-17 1984-06-20 Hoechst Ag, 6230 Frankfurt Neue 2-azabicyclo(2.2.1)heptan-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-azabicyclo(2.2.1)heptan-derivate als zwischenprodukte und verfahren zu deren herstellung
DE3303344A1 (de) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern
US4693996A (en) * 1985-12-23 1987-09-15 Warner-Lambert Company Method of treating heart failure and medicaments therefor
DE3707911C1 (de) * 1987-03-12 1988-03-31 Texaco Ag Bicyclische Aminkatalysatoren
FR2619813B1 (fr) * 1987-08-28 1991-05-03 Adir Nouveaux derives de l'acide aza - 2 bicyclooctane carboxylique - 3, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2635684A1 (fr) * 1988-08-24 1990-03-02 Adir Utilisation de derives de l'acide aza - 2 bicyclooctane (2.2.2) carboxylique - 3 pour l'obtention de medicaments destines au traitement des maladies consecutives a l'alteration de la paroi vasculaire ainsi qu'aux troubles de la microcirculation
JPH0426348U (es) * 1990-06-25 1992-03-02
TW197945B (es) * 1990-11-27 1993-01-11 Hoechst Ag
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
PT796855E (pt) 1996-03-20 2002-07-31 Hoechst Ag Inibicao da reabsorcao nos ossos e antagonistas de vitronectina
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US7001911B2 (en) * 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
AU8821301A (en) 2000-06-28 2002-01-08 Bristol Myers Squibb Co Selective androgen receptor modulators and methods for their identification, design and use
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
ATE404544T1 (de) * 2001-12-19 2008-08-15 Bristol Myers Squibb Co Kondensierte heterocyclische verbindungen und deren analoga; modulatoren der funktion von nukleären hormonrezeptoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE94175C (es) *
GB1095105A (en) * 1965-04-12 1967-12-13 Scherico Ltd Novel n-(phenyl-sulfonyl)-isoquinuclidine-carboxamides
US3740408A (en) * 1967-09-11 1973-06-19 Upjohn Co Oxygenated 3-aza bicyclo(3,3,1)nonanes
IE52663B1 (en) * 1980-04-02 1988-01-20 Warner Lambert Co Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids

Also Published As

Publication number Publication date
CA1183140A (fr) 1985-02-26
DK460181A (da) 1982-04-22
IE51823B1 (en) 1987-04-01
KR830007570A (ko) 1983-10-21
YU245481A (en) 1984-04-30
GR75389B (es) 1984-07-13
DK162444C (da) 1992-03-23
NO155098B (no) 1986-11-03
OA06930A (fr) 1983-05-31
FR2525604B2 (fr) 1985-06-07
PH17338A (en) 1984-08-01
EP0051020A1 (fr) 1982-05-05
EP0051020B1 (fr) 1984-08-08
NO813541L (no) 1982-04-22
FI73678C (fi) 1987-11-09
ATE8892T1 (de) 1984-08-15
ZA817251B (en) 1982-09-29
FR2525604A2 (fr) 1983-10-28
AR228621A1 (es) 1983-03-30
DE3165428D1 (en) 1984-09-13
YU42587B (en) 1988-10-31
ES8301927A1 (es) 1983-01-01
AU7662481A (en) 1982-04-29
PT73857B (fr) 1983-01-25
KR860001877B1 (ko) 1986-10-24
AU540609B2 (en) 1984-11-29
EG15419A (en) 1986-03-31
IE812460L (en) 1982-04-21
FI73678B (fi) 1987-07-31
DK162444B (da) 1991-10-28
HU185058B (en) 1984-11-28
JPS61126025A (ja) 1986-06-13
FR2492381A1 (fr) 1982-04-23
FR2492381B1 (es) 1983-08-12
US4397857A (en) 1983-08-09
FI813279L (fi) 1982-04-22
MA19307A1 (fr) 1982-07-01
IL64075A0 (en) 1982-01-31
JPS6112911B2 (es) 1986-04-10
JPS6146453B2 (es) 1986-10-14
NZ198701A (en) 1984-07-06
PT73857A (fr) 1981-11-01
DD201891A5 (de) 1983-08-17
MX155032A (es) 1988-01-21
JPS5798281A (en) 1982-06-18
SU1138022A3 (ru) 1985-01-30
ES506222A0 (es) 1983-01-01

Similar Documents

Publication Publication Date Title
NO155098C (no) Analogifremgangsmaate ved fremstilling av farmasoeytisk aktive aza-bicyklo-oktan-karboksylsyrer.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO160780C (no) Analogifremgangsmaate ved fremstilling av substituerte iminodisyrer.
NO792787L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO158679C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-penem-3-karboksylsyreforbindelser.
NO155290C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme sulfonylurinstoffderivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO147949C (no) Kontinuerlig fremgangsmaate for fremstilling av karboksylpersyrer.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO883046D0 (no) Fremgangsmaate til fremstilling av chinolonkarboksylsyrer.
NO157735C (no) Fremgangsmaate for fremstilling av alfa-arylalkansyrer.
NO152787C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner.
NO153853C (no) Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner.
IT7827827A0 (it) Procedimento per la desalificazione di residui di distilleria.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO164598C (no) Fremgangsmaate for fremstilling av klormetylestere av penicillansyrer.
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO153141C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner.
NO790328L (no) Fremgangsmaate ved fremstilling av derivater av nafthyl-1-eddiksyre.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO791293L (no) Fremgangsmaate for fremstilling av svovelholdige n-benzylaminosyrer